Update on the clinical use of buprenorphine: In opioid-related disorders
Ducharme et al.
cfp 2012;58:37-41.
ABSTRACT
| FULL TEXT
Mise a jour sur l'utilisation clinique de la buprenorphine: pour les troubles relies aux opioides
Ducharme et al.
cfp 2012;58:e9-e14.
FULL TEXT
The First Universal Opioid Ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): Characterization of the In Vitro Profile and In Vivo Behavioral Effects in Mouse Models of Acute Pain and Cocaine-Induced Reward
Khroyan et al.
J. Pharmacol. Exp. Ther. 2011;336:952-961.
ABSTRACT
| FULL TEXT
Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings
Vlahov et al.
Clinical Infectious Diseases 2010;50:S114-S121.
ABSTRACT
| FULL TEXT
Nociceptin/Orphanin FQ Receptor Activation Attenuates Antinociception Induced by Mixed Nociceptin/Orphanin FQ/{micro}-Opioid Receptor Agonists
Khroyan et al.
J. Pharmacol. Exp. Ther. 2009;331:946-953.
ABSTRACT
| FULL TEXT
Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial
Woody et al.
JAMA 2008;300:2003-2011.
ABSTRACT
| FULL TEXT
SR 16435 [1-(1-(Bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a Novel Mixed Nociceptin/Orphanin FQ/{micro}-Opioid Receptor Partial Agonist: Analgesic and Rewarding Properties in Mice
Khroyan et al.
J. Pharmacol. Exp. Ther. 2007;320:934-943.
ABSTRACT
| FULL TEXT
Buprenorphine Use: The International Experience
Carrieri et al.
Clinical Infectious Diseases 2006;43:S197-S215.
ABSTRACT
| FULL TEXT
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales et al.
JAMA 2006;296:47-55.
ABSTRACT
| FULL TEXT
Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials
Ciraulo et al.
J Clin Pharmacol 2006;46:179-192.
ABSTRACT
| FULL TEXT
Comparison of Intravenous Buprenorphine and Methadone Self-Administration by Recently Detoxified Heroin-Dependent Individuals
Comer et al.
J. Pharmacol. Exp. Ther. 2005;315:1320-1330.
ABSTRACT
| FULL TEXT
Comparison of Pharmacological Treatments for Opioid-Dependent Adolescents: A Randomized Controlled Trial
Marsch et al.
Arch Gen Psychiatry 2005;62:1157-1164.
ABSTRACT
| FULL TEXT
Buprenorphine: Its Role in Preventing HIV Transmission and Improving the Care of HIV-Infected Patients with Opioid Dependence
Sullivan and Fiellin
Clinical Infectious Diseases 2005;41:891-896.
ABSTRACT
| FULL TEXT
Treatment of Opioid Dependence and Coinfection with HIV and Hepatitis C Virus in Opioid- Dependent Patients: The Importance of Drug Interactions between Opioids and Antiretroviral Agents
McCance-Katz
Clinical Infectious Diseases 2005;41:S89-S95.
ABSTRACT
| FULL TEXT
Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics
Yassen et al.
J. Pharmacol. Exp. Ther. 2005;313:1136-1149.
ABSTRACT
| FULL TEXT
Research Note -- Review of Corrections-Based Therapy for Opiate-Dependent Patients: Implications for Buprenorphine Treatment among Correctional Populations
Smith-Rohrberg et al.
Journal of Drug Issues 2004;34:451-480.
ABSTRACT
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT
| FULL TEXT
Buprenorphine-Induced Antinociception Is Mediated by {micro}-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors
Lutfy et al.
J. Neurosci. 2003;23:10331-10337.
ABSTRACT
| FULL TEXT
Transplacental Transfer and Metabolism of Buprenorphine
Nanovskaya et al.
J. Pharmacol. Exp. Ther. 2002;300:26-33.
ABSTRACT
| FULL TEXT
Effects of Infusion Rate of Intravenously Administered Morphine on Physiological, Psychomotor, and Self-Reported Measures in Humans
Marsch et al.
J. Pharmacol. Exp. Ther. 2001;299:1056-1065.
ABSTRACT
| FULL TEXT
Buprenorphine: "Field Trials" of a New Drug
Agar et al.
Qual Health Res 2001;11:69-84.
ABSTRACT
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor and Fiellin
ANN INTERN MED 2000;133:40-54.
ABSTRACT
| FULL TEXT
14-Methoxymetopon, A Potent Opioid, Induces No Respiratory Depression, Less Sedation, and Less Bradycardia than Sufentanil in the Dog
Freye et al.
Anesth. Analg. 2000;90:1359-1364.
ABSTRACT
| FULL TEXT
Assessment of Opioid Partial Agonist Activity with a Three-Choice Hydromorphone Dose-Discrimination Procedure
Jones et al.
J. Pharmacol. Exp. Ther. 1999;289:1350-1361.
ABSTRACT
| FULL TEXT
Human Buprenorphine N-Dealkylation Is Catalyzed by Cytochrome P450 3A4
Kobayashi et al.
Drug Metab. Dispos. 1998;26:818-821.
ABSTRACT
| FULL TEXT
Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine
Everhart et al.
Clin. Chem. 1997;43:2292-2302.
ABSTRACT
| FULL TEXT
Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Buprenorphine and Morphine in Healthy Volunteers
Zacny et al.
J. Pharmacol. Exp. Ther. 1997;282:1187-1197.
ABSTRACT
| FULL TEXT
Discriminative Stimulus Effects of l-alpha -Acetylmethadol (LAAM), Buprenorphine and Methadone in Morphine-Treated Rhesus Monkeys
Brandt et al.
J. Pharmacol. Exp. Ther. 1997;282:574-584.
ABSTRACT
| FULL TEXT
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Schottenfeld et al.
Arch Gen Psychiatry 1997;54:713-720.
ABSTRACT
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling et al.
Arch Gen Psychiatry 1996;53:401-407.
ABSTRACT
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson et al.
JAMA 1992;267:2750-2755.
ABSTRACT
Review article : Opioid analgesics in the management of pain in patients with cancer. A review
Hanks and Hoskin
Palliat Med 1987;1:1-25.
